Other
Endoscopy
0
Pipeline Programs↗
0
Active Trials↗
4
Companies Involved↗
Endoscopy is an early-stage landscape with 0 programs across 4 companies. The most active players are Nihon Pharmaceutical Co., Ltd, Merck & Co., Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
35
clinical trials
Completed20 · 57%
Unknown status11 · 31%
Terminated3 · 9%
Withdrawn1 · 3%
Clinical Trials
Trial Activity
35 trials
Nasal Prep for Nasendoscopy in Children
Completed·—·Phase 4·NCT01351298·69 enrolled
Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy
Completed·—·N/A·NCT03662113·200 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)